https://xl888inhibitor.com/dat....aset-on-researchers-
Kinase task screening identified activation of mitogen-activated protein kinase (MAPK) c-Jun N-terminal protein kinase (JNK1/2) to be one of several main molecular method of MomC anticancer task. Practical assays demonstrated a particular and selective JNK1/2 activation before the induction of various other mobile demise associated processes. Inhibition of JNK1/2 by pretreatment using the JNK-inhibitor SP600125 antagonized cytotoxic task for the marine compound. Mo
Like
Comment
Share
